Drugplain

Lifyorli

Relacorilant · KIT · Corcept Therapeutics Incorporated

No Recall History
Plain English

Lifyorli is a kit containing relacorilant, taken oral. Manufactured by Corcept Therapeutics Incorporated.

Key Facts

Brand Name
Lifyorli
Generic Name
Relacorilant
NDC Code (Product)
76346-550
Manufacturer
Corcept Therapeutics Incorporated
Dosage Form
KIT
Route
ORAL
Marketing Status
Application #
NDA220641
Marketing Start
03/25/2026

Recall History

No Recall History

Frequently Asked Questions

What is Lifyorli used for?

Lifyorli contains Relacorilant. It is a kit taken oral. Consult your doctor for specific uses.

Is Lifyorli a controlled substance?

Lifyorli is not classified as a controlled substance by the DEA.

What is the generic name for Lifyorli?

The generic name for Lifyorli is Relacorilant. There are no other listed brand versions of Relacorilant.

What is the NDC code for Lifyorli ?

The NDC (National Drug Code) for Lifyorli is 76346-550, listed by Corcept Therapeutics Incorporated.

Product NDC

76346-550

Package NDC

76346-550-03

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)